Login

HERNAN CHIESSA - Head of Press and Communications at Metrogas, discusses warnings on the use of... Federico Barni, CEO of Bumeran, participates. 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Visionary Leadership: Darryl Abotomey on Bapcor's Journey and Future Aspirations | Darryl Abotomey, CEO, Bapcor Ltd.
00:10:00
Mineral Investindo Tbk Partners with ADMR | Harry Kesuma Tanoto, CEO of Pt Cita Mineral Investindo Tbk
00:10:00
Business Evolution and AI: A Conversation with Michael Gerstenzang | Michael A. Gerstenzang - Partner of Cleary Gottlieb Steen & Hamilton LLP
00:10:00
Anton Pillay, CEO of Coronation Fund Managers, discusses the company's adjustment to payment processes in a "#PayIn30" initiative.
00:10:00
building the future through technology|Alex Rampell,General Partner,Andreessen Horowitz
00:00:00
Alligator Bioscience - CEO Statement - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Excelsior Gold: Advancing Kalgoorlie-Based Gold Project with Strong Potential
00:10:00
committed to maintaining the highest legal and ethical standards in conducting its business|Ryan Tolkin,CEO,Schonfeld Securities LLC
00:10:00
The Evolution of Work: Mark Dixon on the Rise of Flexible Spaces | Mark Dixon - Founder and CEO, IWG
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Samsara CEO Sanjit Biswas joins 'TechCheck' to discuss the company's recent IPO and the impact of spiking growth rates.
00:10:00
Balancing Growth and Capital Preservation: Mark Burgess on the Bennelong Kardinia Absolute Return Fund | Mark Burgess - Portfolio Manager, Kardinia Capital

© 2017 - Neuhu+